Jail and treatment staff attitudes regarding MOUDs before and after an implementation intervention

References

• American Society of Addiction Medicine (2015). The ASAM: national practice guideline for the use of medications in the treatment of addiction involving opioid use. American Society of Addiction Medicine. Retrieved from https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf?sfvrsn=24
   Google Scholar
• Blanco, C., & Volkow, N. D. (2019). Management of opioid use disorder in the USA: present status and future directions. Lancet, 393(10182), 1760–1772. https://doi.org/10.1016/S0140-6736(18)33078-2
   PubMed Web of Science ®Google Scholar
• Bronson, J., & United States Bureau of Justice Statistics (2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009, 1995–2013 (Ser. Special report). U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Retrieved from https://permanent.fdlp.gov/gpo88216/dudaspji0709.pdf____L.pdf
   Google Scholar
• Carson, E. A., & Cowhig, M. P. (2020). Mortality in local jails, 2000–2016 – Statistical tables. United States Department of Justice. Retrieved from https://www.bjs.gov/index.cfm?ty=pbdetail&iid=6767
   Google Scholar
• Centers for Disease Control and Prevention (2020). Wide-ranging online data for epidemiologic research (WONDER). CDC, National Center for Health Statistics. Retrieved from http://wonder.cdc.gov
   Google Scholar
• Evans, E. A., Wilson, D., & Friedmann, P. D. (2022). Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, 231, 109254. https://doi.org/10.1016/j.drugalcdep.2021.109254
   PubMed Web of Science ®Google Scholar
• Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., O'Connell, D. J., Knudsen, H. K., Shafer, M. S., Hall, E., … Frisman, L. K. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9–18. https://doi.org/10.1080/08897077.2011.611460
   PubMed Web of Science ®Google Scholar
• Friedmann, P. D., Ducharme, L. J., Welsh, W., Frisman, L., Knight, K., Kinlock, T., Mitchell, S. G., Hall, E., Urbine, T., Gordon, M., Abdel-Salam, S., O’Connell, D., Albizu-Garcia, C., Knudsen, H., Duval, J., Fenster, J., & Pankow, J. (2013). A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: Study protocol. Health & Justice, 1, 6. https://doi.org/10.1186/2194-7899-1-6
   Google Scholar
• Fu, J. J., Zaller, N. D., Yokell, M. A., Bazazi, A. R., & Rich, J. D. (2013). Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the united states. Journal of Substance Abuse Treatment, 44(5), 502–505. https://doi.org/10.1016/j.jsat.2012.10.005
   PubMed Web of Science ®Google Scholar
• Gelman, A., & Hill, J. (2007). Data analysis using regression and multilevel/hierarchical models. Cambridge University Press.
   Google Scholar
• Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Fitzgerald, T. T., O’Grady, K. E., & Vocci, F. J. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post‐release. Addiction, 103(8), 1333–1342. https://doi.org/10.1111/j.1360-0443.2008.002238.x
   PubMed Web of Science ®Google Scholar
• Green, T. C., Clarke, J., Brinkley-Rubinstein, L., Marshall, B. D., Alexander-Scott, N., Boss, R., & Rich, J. D. (2018). Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiatry, 75(4), 405–407. https://doi.org/10.1001/jamapsychiatry.2017.4614
   PubMed Web of Science ®Google Scholar
• Kitson, A., Harvey, G., & McCormack, B. (1998). Enabling the implementation of evidence based practice: A conceptual framework. Quality in Health Care, 7(3), 149–158. https://doi.org/10.1136/qshc.7.3.149
   PubMedGoogle Scholar
• Kinlock, T. W., Gordon, M. S., Schwartz, R. P., O'Grady, K., Fitzgerald, T. T., & Wilson, M. (2007, December 1). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91(2–3), 220–227. https://doi.org/10.1016/j.drugalcdep.2007.05.022
   PubMed Web of Science ®Google Scholar
• Klein, A. (2018). Jail-based medication-assisted treatment: Promising practices, guidelines, and resources for the field. Bureau of Justice Assistance. Retrieved from https://www.sheriffs.org/publications/Jail-Based-MAT-PPG.pdf
   Google Scholar
• Krawczyk, N., Picher, C. E., Feder, K. A., & Saloner, B. (2017). Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Affairs, 36(12), 2046–2053. https://doi.org/10.1377/hlthaff.2017.0890
   PubMed Web of Science ®Google Scholar
• Lee, J. D., McDonald, R., Grossman, E., McNeely, J., Laska, E., Rotrosen, J., & Gourevitch, M. N. (2015). Opioid treatment at release from jail using extended‐release naltrexone: a pilot proof‐of‐concept randomized effectiveness trial. Addiction, 110(6), 1008–1014. https://doi.org/10.1111/add.12894
   PubMed Web of Science ®Google Scholar
• Lopez, G. (2018). How America’s prisons are fueling the opioid epidemic. Vox. Retrieved March 26, 2018, from https://www.vox.com/policy-and-politics/2018/3/13/17020002/prison-opioid-epidemic-medications-addiction
   Google Scholar
• Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post‐release: A randomized clinical trial. Drug and Alcohol Dependence, 99(1–3), 222–230. https://doi.org/10.1016/j.drugalcdep.2008.08.006
   PubMed Web of Science ®Google Scholar
• Maruschak, L. M., Minton, T. D., & Zeng, Z. (2023). Opioid use disorder screening and treatment in local jails. United States Department of Justice, 2019. Retrieved from https://bjs.ojp.gov/document/oudstlj19.pdf
   Google Scholar
• McDonald, J. H. (2014). Handbook of biological statistics (3rd ed.). Sparky House Publishing.
   Google Scholar
• Mitchell, S. G., Monico, L. B., Gordon, M. S., Blue, T. R., Salizzoni, A., & Schwartz, R. P. (2020). An implementation process evaluation for the planning initiative to build bridges between jail and community treatment for opioid use disorder. Retrieved from https://www.jcoinctc.org/an-implementation-process-evaluation-for-the-bja-arnold-ventures-building-bridges-project/
   Google Scholar
• National Commission on Correctional Health Care (2016). Standards for opioid treatment programs in correctional facilities. Standard O-E-02 Health Assessments. National Commission on Correctional Health Care.
   Google Scholar
• National Institute on Drug Abuse (2016a). Advancing addiction science, effective treatment for opioid addiction. Retrieved from https://www.drugabuse.gov/publications/effective-treatments-opioid-addiction/effective-treatments-opioid-addiction
   Google Scholar
• National Institute on Drug Abuse (2016b, November 1). Effective treatments for opioid addiction. Retrieved from https://www.drugabuse.gov/eff ective-treatments-opioid-addiction-0
   Google Scholar
• Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug and Alcohol Dependence, 105(1–2), 83–88. https://doi.org/10.1016/j.drugalcdep.2009.06.015
   PubMed Web of Science ®Google Scholar
• O’Brien, C., & Cornish, J. W. (2006). Naltrexone for probationers and prisoners. Journal of Substance Abuse Treatment, 31(2), 107–111. https://doi.org/10.1016/j.jsat.2006.06.002
   PubMed Web of Science ®Google Scholar
• O’Connor, A., & Bowling, N. (2020). Initial management of incarcerated pregnant women with opioid use disorder. Journal of Correctional Health Care, 26(1), 17–26. https://doi.org/10.1177/1078345819897063
   PubMed Web of Science ®Google Scholar
• Rich, J. D., Boutwell, A. E., Shield, D. C., Key, R. G., McKenzie, M., Clarke, J. G., & Friedmann, P. D. (2005). Attitudes and practices regarding the use of methadone in US state and federal prisons. Journal of Urban Health, 82(3), 411–419. https://doi.org/10.1093/jurban/jti072
   PubMed Web of Science ®Google Scholar
• Rich, J. D., McKenzie, M., Larney, S., Wong, J. B., Tran, L., Clarke, J., Noska, A., Reddy, M., & Zaller, N. (2015). Methadone continuation versus forced withdrawal on incarceration in a combined U.S. prison and jail: A randomized, open-label trial. Lancet, 386(9991), 350–359. https://doi.org/10.1016/S0140-6736(14)62338-2
   PubMed Web of Science ®Google Scholar
• Rycroft-Malone, J. (2004). The PARIHS framework—A framework for guiding the implementation of evidence-based practice. Journal of Nursing Care Quality, 19(4), 297–304. https://doi.org/10.1097/00001786-200410000-00002
   PubMed Web of Science ®Google Scholar
• Rye, M., Torres, E. M., Friborg, O., Skre, I., & Aarons, G. A. (2017). The Evidence-based Practice Attitude Scale-36 (EBPAS-36): A brief and pragmatic measure of attitudes to evidence-based practice validated in US and Norwegian samples. Implementation Science, 12(1), 44. https://doi.org/10.1186/s13012-017-0573-0
   PubMedGoogle Scholar
• Schwartz, R. P., Kelly, S. M., Mitchell, S. G., O'Grady, K. E., Sharma, A., & Jaffe, J. H. (2020). Methadone treatment of arrestees: A randomized clinical trial. Drug and Alcohol Dependence, 206, 107680. https://doi.org/10.1016/j.drugalcdep.2019.107680
   PubMed Web of Science ®Google Scholar
• Scott, C. K., Dennis, M. L., Grella, C. E., Mischel, A. F., & Carnevale, J. (2021). The impact of the opioid crisis on US state prison systems. Health & Justice, 9(1), 17. https://doi.org/10.1186/s40352-021-00143-9
   PubMedGoogle Scholar
• Snijders, T. A. B., & Bosker, R. J. (2012). Multilevel analysis: An introduction to basic and advanced multilevel modeling (2nd ed.). Sage.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/
   Google Scholar
• Substance Abuse and Mental Health Services Administration (2021). Medications for opioid use disorder. Treatment Improvement Protocols (TIPS), 63. Retrieved from https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002
   Google Scholar
• Smith, K., & Strashny, A. (2016, April 26). Characteristics of criminal justice system referrals discharged from substance abuse treatment and facilities with specially designed criminal justice programs. The CBHSQ Report. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Retrieved from https://www.samhsa.gov/data/sites/default/files/report_2321/ShortReport-2321.html
   Google Scholar
• Sugarman, O. K., Bachhuber, M. A., Wennerstrom, A., Bruno, T., & Springgate, B. F. (2020). Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health. PLOS One, 15(1), e0227968. https://doi.org/10.1371/journal.pone.0227968
   PubMed Web of Science ®Google Scholar
• Vestal, C. (2018). New momentum for addiction treatment behind bars. Retrieved from https://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2018/04/04/new-momentum-for-addiction-treatment-behind-bars
   Google Scholar
• Zaller, N., McKenzie, M., Friedmann, P. D., Green, T. C., McGowan, S., & Rich, J. D. (2013). Initiation of buprenorphine during incarceration and retention in treatment upon release. Journal of Substance Abuse Treatment, 45(2), 222–226. https://doi.org/10.1016/j.jsat.2013.02.005
   PubMed Web of Science ®Google Scholar